Profile
Chen Zong is currently President at Harbour BioMed (Shanghai) Co., Ltd. and President at HBM Holdings Ltd., both positions starting in 2026.
Formerly, Dr. Zong was President & Chief Operating Officer at Seven & Eight Biopharmaceuticals, Inc. Education includes a doctorate from The Rockefeller University and an MBA from The Wharton School of the University of Pennsylvania.
Adam Zong active positions
| Companies | Position | Start |
|---|---|---|
| HBM HOLDINGS LIMITED | President | 15/04/2026 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | President | 15/04/2026 |
Former positions of Adam Zong
| Companies | Position | End |
|---|---|---|
Seven & Eight Biopharmaceuticals, Inc.
Seven & Eight Biopharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of novel immunotherapies for cancer | President | - |
Training of Adam Zong
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Health Technology |
HBM Holdings Ltd.
HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
Seven & Eight Biopharmaceuticals, Inc.
Seven & Eight Biopharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of novel immunotherapies for cancer | Health Technology |
- Stock Market
- Insiders
- Adam Zong
















